An end to breast cancer? California company develops groundbreaking vaccine with promising future

An estimated one in eight women will develop breast cancer in their lifetime, killing on average 42,000 a year in the U.S. But what if a vaccine could significantly lower each woman’s chance of ever getting it in the first place?